Insys Therapeutics, Inc. (10)
Browse by Contract Category
Contracts
-
Second Amendment to Transition Services Agreement, dated as of January 30, 2020, by and between Benuvia Therapeutics Inc. and Insys Therapeutics, Inc
(Filed With SEC on February 5, 2020)
-
Asset Purchase Agreement, dated as of December 2, 2019, by and between Renaissance Lakewood, LLC and Insys Therapeutics, Inc
(Filed With SEC on December 3, 2019)
-
Amendment to Manufacturing and Supply Agreement, dated as of February 26, 2019, by and between the Registrant and Renaissance
(Filed With SEC on May 13, 2019)
-
Amendment to Transition Services Agreement, dated as of December 30, 2019, by and between Benuvia Therapeutics Inc. and Insys Therapeutics, Inc
(Filed With SEC on January 6, 2020)
-
Transition Services Agreement, dated as of October 31, 2019, by and between Chilion Group Holdings US, Inc. and Insys Therapeutics, Inc
(Filed With SEC on November 4, 2019)
-
Amendment No. 1 to Asset Purchase Agreement, dated as of October 23, 2019, by and between Chilion Group Holdings US, Inc. and Insys Therapeutics, Inc
(Filed With SEC on October 25, 2019)
-
Asset Purchase Agreement, dated as of September 25, 2019, by and between Pharmbio Korea, Inc. and Insys Therapeutics, Inc
(Filed With SEC on September 26, 2019)
-
Asset Purchase Agreement, dated as of September 1, 2019, by and between BTcP Pharma, LLC and Insys Therapeutics, Inc
(Filed With SEC on September 3, 2019)
-
Asset Purchase Agreement, dated as of August 6, 2019, by and between Chilion Group Holdings US, Inc. and Insys Therapeutics, Inc
(Filed With SEC on August 8, 2019)
-
Asset Purchase Agreement, dated as of August 5, 2019, by and between Hikma Pharmaceuticals USA Inc. and Insys Therapeutics, Inc
(Filed With SEC on August 8, 2019)